LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress

BACKGROUND: Non-small-cell lung cancer (NSCLC) is one of the most common malignancies worldwide, and cisplatin-based chemotherapy is the main treatment for NSCLC. However, cisplatin resistance of NSCLC cells is a major challenge for NSCLC treatment. MATERIALS AND METHODS: qRT-PCR and Western blot we...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Peng, Han, Wen, Meng, Cunying, Tan, Xiaohong, Liu, Pengfei, Dong, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605833/
https://www.ncbi.nlm.nih.gov/pubmed/36311891
http://dx.doi.org/10.1155/2022/6100176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9605833/
https://www.ncbi.nlm.nih.gov/pubmed/36311891
http://dx.doi.org/10.1155/2022/6100176

Ejemplares similares